University of Nebraska is a clinical research site located in Lincoln, Nebraska, United States 68588.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Nebraska has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: New Onset Refractory Status Epilepticus, New-Onset Refractory Status Epilepticus, Febrile Infection-Related Epilepsy Syndrome (FIRES).
Sponsors: Yale University, University of Nebraska Lincoln, Abbott Nutrition.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Nebraska has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Nebraska has 4 clinical trials on record, with 1 currently active. Their work covers New Onset Refractory Status Epilepticus, New-Onset Refractory Status Epilepticus, Febrile Infection-Related Epilepsy Syndrome (FIRES).
Yes — University of Nebraska holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.